Last update 11 May 2026

RO7771950

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
RO7771950
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
HER2 Positive Breast CancerLocally advanced breast cancerNeoplasm Metastasis
Inactive Indication-
Originator Organization
F. Hoffmann-La Roche Ltd.
Active Organization
Roche Holding AGRoche Holding AGF. Hoffmann-La Roche Ltd.Roche China Holding Ltd.Roche China Holding Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with RO7771950
NCT07413939
/ RecruitingPhase 2/3
A Two-part, Seamless, Multicenter, Randomized, Open-label, Adaptive Phase II/III Study of the Blood-brain Barrier Penetrant RO7771950 Versus Tucatinib, Both in Combination With Trastuzumab and Capecitabine, in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2-Postivie Breast Cancer, With or Without Central Nervous System Metastases
100 Clinical Results associated with RO7771950
Login to view more data
100 Translational Medicine associated with RO7771950
Login to view more data
100 Patents (Medical) associated with RO7771950
Login to view more data
100 Deals associated with RO7771950
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HER2 Positive Breast CancerPhase 3
Canada
Roche Holding AGRoche Holding AG
01 Jun 2026
HER2 Positive Breast CancerPhase 3
Taiwan Province
Roche Holding AGRoche Holding AG
01 Jun 2026
Locally advanced breast cancerPhase 3
Canada
Roche Holding AGRoche Holding AG
01 Jun 2026
Locally advanced breast cancerPhase 3
Taiwan Province
Roche Holding AGRoche Holding AG
01 Jun 2026
Neoplasm MetastasisPhase 3
Canada
Roche Holding AGRoche Holding AG
01 Jun 2026
Neoplasm MetastasisPhase 3
Taiwan Province
Roche Holding AGRoche Holding AG
01 Jun 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free